Abstract
Extra-testicular lesions are usually benign but present with nonspecific grey-scale sonography findings. This study assesses conventional sonographic characteristics in the differentiation of extra-testicular tumoural from inflammatory lesions and whether contrast-enhanced ultrasound has a role. A retrospective database analysis was performed. All patients were examined by experienced sonographers employing standard techniques combining grey-scale, colour Doppler sonography and contrast-enhanced ultrasound. Features recorded were: clinical symptoms, size, location, echogenicity, colour Doppler sonography and contrast-enhanced ultrasound enhancement. Vascularity on colour Doppler sonography and contrast-enhanced ultrasound was graded and compared. The lesions were classified as tumoural or inflammatory. The Chi-square test was used to analyse the sonographic patterns and kappa coefficient to measure the agreement between colour Doppler sonography and contrast-enhanced ultrasound. A total of 30 lesions were reviewed (median diameter 12 mm, range 5–80 mm, median age 52 years, range 18–86 years), including 13/30 tumoural and 17/30 inflammatory lesions. Lesions were hypoechoic (n = 12), isoechoic (n = 6), hyperechoic (n = 2) or mixed (n = 10). Grey-scale characteristics of tumoural vs. inflammatory lesions differed significantly (P = 0.026). On colour Doppler sonography, lesions had no vessels (n = 16), 2–3 vessels (n = 10) and ≥4 vessels (n = 4). On contrast-enhanced ultrasound, lesions showed no vascularity (n = 17), perfusion similar to testis (n = 7) and higher (n = 6). All abscesses identified (n = 9) showed no vascularity on both colour Doppler sonography and contrast-enhanced ultrasound. There was good agreement between these techniques in evaluating vascularity (κ = 0.719) and no significant difference between colour Doppler sonography and contrast-enhanced ultrasound of tumoural vs. inflammatory lesions (P > 0.05). The grey-scale appearances of extra-testicular lesions are essential for characterisation. Colour Doppler sonography and contrast-enhanced ultrasound findings are not useful in that respect. Contrast-enhanced ultrasound is excellent in establishing absence of vascularity.
Keywords: Epididymis, tumour, inflammation, ultrasound, contrast
Introduction
Sonography is vital in the investigation and management of patients who present with a scrotal mass. The site of the scrotal mass is important, with sonography useful in locating the abnormality to an intra-scrotal extra-testicular or intra-testicular position. This is an important distinction in the adult patient; the majority of intra-scrotal extra-testicular abnormalities are benign, with prevalence of malignancy approximately 3–16%.1–5 The commonest lesion in the extra-testicular position in the scrotum is the epididymal cyst or spermatocele, but a solid lesion is more problematic; extra-testicular primary solid neoplasms arise from the epididymis, spermatic cord and para-testicular connective tissues.6 With grey-scale sonography, these lesions have nonspecific appearances, usually presenting as solid lesions close to the testicular capsule of variable echogenicity.1,5 Lipomas are the most common para-testicular neoplasms arising from the spermatic cord, with an adenomatoid lesion being the most common epididymal benign tumour, accounting for 30% of all extra-testicular masses,6–9 both with variable and non-specific appearances on grey-scale sonography. Inflammatory causes such as epididymal-orchitis, abscess, tuberculosis or sarcoidosis also occur in the para-testicular space. Rarely, a fibrous pseudo-tumour or inflammatory pseudo-tumour may occur, thought to be a fibro-inflammatory reaction most commonly involving the tunica albuginea or vaginalis.10 A definite diagnosis is often established by histology. Surgical removal of benign scrotal lesions is not without morbidity and includes tumour recurrence, haematoma and infection, and if the tumour is epididymal based, may result in obstruction of the vas deferens.3
Occasionally, magnetic resonance (MR) imaging is used as a problem-solving tool to further characterise the scrotal lesions, specifically targeting fat content of the abnormality, distinguishing between intra- and extra-testicular masses in the periphery of the testis as well as demonstrating lesion vascularity.6,11,12 Microbubble contrast agents are established in the assessment of focal liver lesions,13 with many investigators assessing the efficacy of microbubble contrast in other organs.14 There has been an increasing interest in the role of contrast-enhanced ultrasound (CEUS) in diagnosis and management of scrotal lesions.15 The use of CEUS can potentially improve the characterisation of testicular lesions in terms of better delineation of the lesions,16–18 establishing their location and pattern of enhancement. Poor or absent enhancement is evident in the majority of non-neoplastic lesions.19,20–24
There have been no reports regarding the appearances of benign and/or inflammatory extra-testicular lesions with CEUS. The aim of this study is to evaluate the conventional sonographic characteristics of extra-testicular intra-scrotal lesions and ascertain whether CEUS has any additional value.
Materials and methods
Ethics Review Board approval was sought for this retrospective study but waived. All patients provided informed verbal consent for the sonographic evaluation including the use of microbubble contrast, which is the standard departmental practice. The patients were selected retrospectively from a departmental database maintained over a period of 5 years (2010–2014) by one of the authors (PSS). All patients were referred by the primary care physician or from Urology, undergoing a routine grey-scale sonographic examination according to departmental protocol, with the addition of colour Doppler sonography (CDS) assessment when required. A CEUS examination for further characterisation of the scrotal lesions was performed by consensus by the practitioners conducting the examination.
All patients were scanned by two experienced operators in testicular sonography and CEUS (PSS 16 years and MES 10 years). A standard testicular sonographic technique was used in all cases with standard high frequency transducers. All grey-scale and CDS examinations were performed with either a 14L5 or 9L4 linear transducer on a Siemens Acuson S2000 system (Siemens Medical Solutions, Mountain view, CA). For CEUS imaging, the 9L4 linear transducer was used with conventional low Mechanical Index (MI) imaging (Cadence Contrast Pulse Sequencing, CPS™, Siemens, Mountain View, CA), after a bolus injection of 4.8 ml of SonoVue™ (Bracco SpA, Milan, Italy) as microbubble contrast media. On grey-scale sonography, characteristics of each lesion including echogenicity in comparison to the adjacent testis, shape, margin, location (upper, mid or lower epididymis or spermatic cord) and the lateralisation (right or left) were described by consensus by two reviewers (PSS, MES).
The vascularity of each lesion on CDS and CEUS imaging was recorded by consensus by the reviewers and divided on CDS imaging as follows: (I) no vascularity; (II) 2–3 vessels; and (III) ≥4 vessels. The vascularity on CEUS was graded as follows: (I) no vascularity; (II) similar vascularity to adjacent testis; (III) more vascularity than adjacent testis. Diagnosis was confirmed at excisional biopsy, MR imaging or stable appearances with follow-up sonography demonstrating continuing characteristic sonographic features or resolution. For statistical analysis, due to the small number of some types of lesions, two groups were formed, the tumoural and the non-tumoural or inflammatory lesions. The former group included lipoma, adenomatoid and leiomyoma, whereas the latter group included abscesses, pseudo-tumours, infarction and sarcoidosis. The Chi-square test with a significance level set to 0.05 was used to indicate any statistically significant difference in the frequencies of echogenicity and vascularity on CDS and CEUS patterns between these two groups. The agreement between CDS and CEUS in the characterisation of lesion vascularity was evaluated by calculating the kappa coefficient. The SPSS package (IBM SPSS Statistics v 22) was used to conduct all analyses.
Results
The ultrasonographic findings are summarised in Table 1. A total of 30 patients were reviewed, age range 18–86 years with median age of 52 years. There was equal distribution of lesions between right and left scrotum (right n = 17, left n = 13). A painless scrotal mass (n = 18) was the most frequent clinical reason for the sonographic examination; other lesions were incidental findings (n = 12). The distribution of the lesions was as follows: lower epididymis (n = 19), mid epididymis (n = 3), upper epididymis (n = 5), spermatic cord (n = 2) and one lesion along the entire epididymis. The lesions were hypoechoic (n = 12), isoechoic (n = 6), hyperechoic (n = 2) and mixed echoic (n = 10). After dividing the lesions into the tumoural and non-tumoural inflammatory groups, tumoural lesions (n = 13) were predominantly hypoechoic and isoechoic, while non-tumoural lesions (n = 17) tended to be hypoechoic or of mixed echogenicity. The differences in the echogenicity pattern on grey-scale sonography were statistically significant (P = 0.026). The echogenicity patterns of the lesions are summarised in Table 2. All lesions, apart from the epididymal abscess, had well defined margins. The range of maximum diameter of the lesions was 5–80 mm.
Table 1.
The findings on grey-scale, colour Doppler and contrast-enhanced ultrasound, histology and follow up/additional imaging are listed for each lesion, for consecutive patients
| Diagnosis | Age | Grey-scale appearance |
Colour Doppler ultrasound |
Contrast-enhanced ultrasound |
Follow up | |||
|---|---|---|---|---|---|---|---|---|
| Lesion location | Size (mm) | Description | Lesion vascularity | Lesion vascularity (compared to adjacent testis) | ||||
| 1 | Adenomatoid | 35 | Right lower epididymis | 11 | Circumscribed isoechoic with central areas of low reflectivity | 2–3 vessels | Similar vascularity | No change |
| 2 | Epididymal abscess | 82 | Right lower epididymis | 22 | Irregular margins mixed predominantly hypoechoic | 0 vessels | No vascularity | Reduction in size |
| 3 | Adenomatoid | 51 | Left lower epididymis | 8 | Circumscribed hypoechoic | 2–3 vessels | Similar vascularity | No change |
| 4 | Adenomatoid | 31 | Left lower epididymis | 9 | Circumscribed isoechoic | 0 vessels | No vascularity | No change |
| 5 | Lipoma | 43 | Right mid epididymis | 6 | Circumscribed hyperechoic | ≥4 vessels | Increased vascularity | No change |
| 6 | Inflammatory Pseudo-tumour | 44 | Left upper epididymis | 9 | Circumscribed hypoechoic | 0 vessels | No vascularity | No follow up |
| 7 | Lipoma | 31 | Right full length epididymis | 80 | Circumscribed isoechoic | 0 vessels | No vascularity | Magnetic resonance imaging |
| 8 | Inflammatory Pseudo-tumour | 79 | Left Iower epididymis | 9 | Circumscribed hypoechoic | ≥4 vessels | Similar vascularity | No follow up |
| 9 | Epididymal abscess | 37 | Right upper epididymis | 15 | Circumscribed hypoechoic | 0 vessels | No vascularity | Histology |
| 10 | Sarcoidosis | 48 | Right upper epididymis | 12 | Circumscribed mixed predominantly hypoechoic | 2–3 vessels | Increased vascularity | Reduction in size |
| 11 | Adenomatoid | 57 | Right mid epididymis | 14 | Circumscribed hypoechoic | ≥4 vessels | Increased vascularity | No change |
| 12 | Adenomatoid | 44 | Left lower epididymis | 36 | Circumscribed hypoechoic | 2–3 vessels | Similar vascularity | Histology |
| 13 | Tuberculous abscess | 50 | Right lower epididymis | 11 | Circumscribed hypoechoic | 2–3 vessels | Similar vascularity | Increase in size post-surgery |
| 14 | Lipoma | 86 | Left lower epididymis | 14 | Circumscribed hypoechoic | 2–3 vessels | No vascularity | No change |
| 15 | Epididymal abscess | 84 | Right upper epididymis | 10 | Circumscribed mixed echogenicity | 0 vessels | No vascularity | Resolution |
| 16 | Epididymal abscess | 85 | Left lower epididymis | 5 | Irregular margins mixed echogenicity | 0 vessels | No vascularity | Histology (testis infarction) |
| 17 | Epididymal abscess | 73 | Left lower epididymis | 32 | Circumscribed mixed echogenicity | 0 vessels | No vascularity | Histology (fungal, testis infarction) |
| 18 | Epididymal abscess | 80 | Right lower epididymis | 20 | Circumscribed mixed echogenicity | 0 vessels | No vascularity | No follow-up |
| 19 | Epididymal abscess | 50 | Right lower epididymis | 12 | Circumscribed mixed echogenicity | 0 vessels | No vascularity | Histology (partial testis infarction) |
| 20 | Adenomatoid | 52 | Right upper epididymis | 18 | Circumscribed mixed echogenicity | 2–3 vessels | Increased vascularity | Histology (with central hemorrhage) |
| 21 | Multifocal tuberculous abscess | 41 | Left lower epididymis | 10 | Circumscribed hypoechoic | ≥4 vessels | Increased vascularity | Histology (testis and para-testicular tissue) |
| 22 | Epididymal abscess | 69 | Right lower epididymis | 13 | Circumscribed mixed echogenicity | 0 vessels | No vascularity | Resolution |
| 23 | Epididymal abscess | 72 | Left lower epididymis | 52 | Ill-defined isoechoic | 2–3 vessels | Similar vascularity | Histology (testis infarction) |
| 24 | Epididymal abscess | 20 | Right lower epididymis | 30 | Circumscribed mixed echogenicity | 0 vessels | No vascularity | Reduction in size |
| 25 | Lipoma | 47 | Left lower epididymis | 33 | Circumscribed hyperechoic | 2–3 vessels | Increased vascularity | Histology |
| 26 | Adenomatoid | 33 | Right lower epididymis | 12 | Circumscribed isoechoic | 0 vessels | No vascularity | No follow-up |
| 27 | Chronic Inflammation of spermatic cord | 84 | Left spermatic cord | 26 | Circumscribed mixed echogenicity | 0 vessels | No vascularity | Histology |
| 28 | Extra-testicular haematoma | 18 | Right lower epididymis | 30 | Circumscribed hypoechoic | 0 vessels | No vascularity | Resolution |
| 29 | Sperm granuloma | 32 | Right mid epididymis | 7 | Circumscribed isoechoic | 0 vessels | No vascularity | Unchanged |
| 30 | Spermatic cord leiomyoma | 56 | Left spermatic cord | 10 | Circumscribed mixed echogenicity | 2–3 vessels | Similar vascularity | Histology |
Table 2.
Grey-scale findings of tumoural and inflammatory lesions
| Echogenicity pattern |
||||
|---|---|---|---|---|
| Lesion type | Hypoechoic | Isoechoic | Hyperechoic | Mixed |
| Tumoural | 4 | 5 | 2 | 2 |
| Inflammatory | 8 | 1 | 0 | 8 |
Chi-square test: P = 0.026
The lesions demonstrated a variable degree of vascularity on CDS; there were 16/30 (53.4%) avascular lesions, 10/30 (33.3%) lesions with 2–3 vessels and only 4/30 (13.3%) lesions perfused by ≥4 vessels. Similarly, on CEUS 17/30 (56.7%) lesions were completely avascular, 7/30 (23.3%) lesions perfused similarly to the adjacent testis and 6/30 (20.0%) lesions with higher perfusion compared to the testis. Absence of vascularity was better and more readily delineated on CEUS in 17/30 (56.7%) cases. The degree of vascularity as detected on both CDS and CEUS was not statistically significantly different between the two groups (P = 0.076 and P = 0.20, respectively). The overall agreement of CDS and CEUS in the characterisation of lesion vascularity was found to be good, with a kappa value calculated as 0.719. Only in five cases, the degree of vascularity detected on CDS did not match the CEUS findings.
The characteristics of tumoural lesions identified were mostly hypoechoic or isoechoic and demonstrated 2–3 vessels on CDS. On CEUS of tumoural lesions, there was variability of the perfusion pattern. Adenomatoid lesions were predominantly hypoechoic and moderately vascularised (Figure 1). Lipomas were hyperechoic, with half of them showing no vascularity on CEUS and half increased vascularity (Figure 2). Inflammatory non tumoural lesions were predominantly hypoechoic or of mixed echogenicity and variably perfused both on CDS and CEUS. The epididymal sarcoid lesion showed a characteristic mixed echogenicity and increased vascularity, consistent with its inflammatory nature (Figure 3). A sperm granuloma was isoechoic and hypo-vascularised (Figure 4). All abscesses identified (n = 9) were avascular on CDS and demonstrated with clarity with CEUS (Figure 5).
Figure 1.
Ultrasound findings in a patient with adenomatoid tumour of the epididymis (Patient 1). Grey-scale ultrasound (a) identified a circumscribed isoechoic lesion with central areas of low reflectivity (arrow) situated in the lower part of the right epididymis. Colour Doppler ultrasound (b) could identify 2–3 vessels (arrows) within the lesion. CEUS image (c) demonstrates similar vascularity (arrows) of the lesion to the adjacent testis (T).
Figure 2.
Ultrasound findings in a patient with a paratesticular lipoma (Patient 14). Grey-scale ultrasound (a) identified a circumscribed hyperechoic lesion (arrow) located in the lower part of the left epididymis. Colour Doppler ultrasound (b) revealed 2–3 blood vessels (arrows). Contrast-enhanced ultrasound (c) revealed no vascularity of the lesion (L), which is relatively hypoechoic compared to the adjacent testis (T).
Figure 3.
Ultrasound findings in a patient with epididymal sarcoid (Patient 10). Grey-scale ultrasound (a) revealed the presence of a circumscribed mass of mixed echogenicity but predominantly hypoechoic (arrow), situated in the upper part of the right epididymis. Colour Doppler ultrasound (b) revealed 2–3 blood vessels (arrows). On contrast-enhanced ultrasound (c), the mass showed increased vascularity (arrows) compared to the normal testicular parenchyma.
Figure 4.
Ultrasound findings in a patient with sperm granuloma (Patient 29). Grey-scale ultrasound (a) identified a circumscribed isoechoic lesion (arrow) situated in the mid part of the right epididymis. Colour Doppler ultrasound (b) revealed no blood vessels within the lesion. Contrast-enhanced ultrasound (c) identified no vascularity within the mass.
Figure 5.
Ultrasound findings in a patient with epididymal abscess (Patient 2). A lesion of mixed echogenicity but predominantly hypoechoic (arrow) was identified in the lower part of the right epididymis (a). Colour Doppler ultrasound (b) revealed the absence of blood vessels within the lesion. CEUS (c) confirmed the absence of vascularity within the mass. Increased peripheral vascularity was noted on both CDS and CEUS (arrows).
Histology was available in 11 patients, establishing the diagnoses of adenomatoid lesion (n = 2), abscess formation (n = 3), chronic tuberculosis (TB) (n = 1), chronic inflammation (n = 2), fungal infection (n = 1), leiomyoma (n = 1) and lipoma (n = 1). One lipoma was assessed on MR imaging. Two patients with suspected lipoma declined surgery and one patient was a surgical risk. Fourteen patients had a follow-up examination, with 13 patients showing stable appearance or resolution of the lesions and one case (scrotal TB abscess) showing an increase in size. Two cases of suspected pseudo-inflammatory fibrous tumours did not have follow-up imaging.
Discussion
The sonographic features of para-testicular lesions in the current series were variable with the majority demonstrating a predominantly well circumscribed, hypoechoic extra-testicular lesion with absence of vascularity both on CDS and CEUS. The echogenicity pattern on grey-scale ultrasound was essential in the appropriate characterisation of extra-testicular lesions as tumoural or inflammatory. The lesion vascularity was also variable, both on CDS and CEUS and could not be reliably used for a differential diagnosis. Furthermore, the addition of CEUS did not improve the CDS interpretation of lesion vascularity or pattern of vascularity, with matching results in the majority of cases. However, as previously described21,23–25 CEUS accurately delineates necrotic tissue in all cases and thus unequivocally establishes the diagnosis of an abscess. Grey-scale imaging of an abscess may not be confirmatory as the majority of abscesses were of mixed echogenicity or hypoechoic. Overall, the combination of grey scale sonography, CDS and CEUS provided confirmation of the extra-testicular location, which despite variable reflectivity and vascularity of each lesion was in favour of a benign pathology.
Grey-scale sonography has been found to be 98–100% sensitive in differentiating between intra-testicular and extra-testicular lesions, without any more recent evidence to reverse this finding.5,26–28 Occasionally, a lesion originating from the capsule or one that is extra-testicular and firm (indenting the capsule and protruding into the testis) can be difficult to localise on the grey-scale sonography. Given the benign nature of these lesions, follow up imaging documenting benign growth or stability is the preferred approach. Patient anxiety or clinical uncertainty may ultimately lead to surgical excision. MR imaging is occasionally used as a problem solving tool in order to characterise the lesion, in particular ascertaining the fat content of a lipoma.29,30 A previous study31 using ultrasonography in the differential diagnosis of focal epididymal lesions concluded that the presence of a hypoechoic or hyperechoic halo favoured the diagnosis of a benign epididymal lesion rather than an inflamed epididymis. In contrast to the findings of the present study, vascularity as assessed on CDS was found to be greater in cases of inflammatory lesions compared to tumoural ones, but these were not abscesses but focal areas of inflammatory tissue. However, the lesion size and the clinical symptoms of tenderness and symptom duration were essential in the image interpretation.31
The addition of CEUS is important due to its ability to better demonstrate lesion characteristics of vascularity, particularly with the true intravascular nature of the contrast, and as such will clearly demonstrate the non-vascularized areas. CEUS therefore aids delineation and sizing of the lesion, as well as helping to establish whether it is intra- or extra-testicular.16,24,25 When the lesion is vascularised, the degree of vascularity detected on CDS matched the CEUS results in the majority of the cases. But unlike intra-testicular lesions, where hypervascularity and malignancy have a strong relationship,17,18 in extra-testicular solid masses, it is difficult to establish a direct link between any pattern of vascularisation and the nature of lesions encountered.1
There are several limitations to this case series: a small number of patients were identified but this reflects the relative rarity of the solid extra-testicular masses. There was no patient with malignant disease identified in this study, a very rare occurrence. As a consequence, differential diagnosis between benign and malignant diseases, in contrast to intra-testicular lesions, where CEUS has been proven accurate,18 cannot be analysed. It is noted that less than 100 cases of liposarcoma and 50 of leiomyosarcoma have been reported.6 Only three patients had histologic diagnosis but in one case additional MR imaging was performed and in the remainder of the cases, follow up imaging confirmed the absence of progression or regression of the lesions in favour of benign pathology.
Conclusion
In conclusion, the para-testicular mass lesions are of benign aetiology in the majority of cases. Conventional grey-scale features play an important role in the characterisation of these patients. The addition of CEUS can better characterise these lesions, particularly their location, but its value in demonstrating vascularity is not significantly superior to CDS, with which it shows good agreement. It is particularly of value when there is a lesion without vascularity present e.g. an abscess. The nonspecific appearances and variable vascularity of the para-testicular lesions, however, precludes CEUS as a definite diagnostic tool in demonstrating subsets of benign disease, but it is useful in differentiating tumour lesions from inflammatory change.
Acknowledgments
We thank the numerous physicians and surgeons who cared for the patients reported in this study.
Declaration of Conflicting Interests
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: VC lectures for Bracco, Samsung and Toshiba. PSS lectures for Bracco, Siemens, Hitachi and GE. MES and AD lecture for Bracco.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
Ethical approval
Local approval to report this review was obtained in conjunction with a larger CEUS study (KCH14-102).
Guarantor
PSS.
Contributorship
PSS, VR, HR, EK, DYH, MES, AD, VC, AMI researched the literature and conceived the study. PSS, HR, EK, VR designed the study overview. PSS, VR, HR performed the data analysis. HR wrote the first draft of the manuscript. PSS, VR wrote the final version of the manuscript. All authors reviewed and approved the final version of the manuscript.
References
- 1.Woodward PJ, Schwab CM, Sesterhenn IA. Extratesticular scrotal masses: radiologic-pathologic correlation. Radiographics 2003; 23: 215–240. [DOI] [PubMed] [Google Scholar]
- 2.Montogomery JS, Bloom DA. The diagnosis and management of scrotal masses. Med Clin North Am 2011; 95: 235–244. [DOI] [PubMed] [Google Scholar]
- 3.Beccia DJ, Krane RJ, Olsson CA. Clinical management of non-testicular intrascrotal tumors. J Urol 1976; 116: 476–479. [DOI] [PubMed] [Google Scholar]
- 4.Mirochnik B, Bhargava P, Dighe MK, et al. Ultrasound evaluation of scrotal pathology. Radiol Clin North Am 2012; 50: 317–332. [DOI] [PubMed] [Google Scholar]
- 5.Frates MC, Benson CB, DiSalvo DN, et al. Solid extratesticular masses evaluated with sonography: pathologic correlation. Radiology 1997; 204: 43–46. [DOI] [PubMed] [Google Scholar]
- 6.Akbar SA, Sayyed TA, Jafri SZH, et al. Multimodality imaging of paratesticular neoplasms and their rare mimics. Radiographics 2003; 23: 1461–1476. [DOI] [PubMed] [Google Scholar]
- 7.Wolfman DJ, Marko J, Gould CF, et al. Mesenchymal extratesticular tumors and tumorlike conditions: from the radiologic pathology archives. Radiographics 2015; 35: 1943–1954. [DOI] [PubMed] [Google Scholar]
- 8.Dell'atti L. Ultrasound diagnosis of unusual extratesticular mass: case report and review of the literature. Arch Ital Urol Androl 2013; 85: 41–43. [DOI] [PubMed] [Google Scholar]
- 9.Dogra VS, Gottlieb RH, Oka M, et al. Sonography of the scrotum. Radiology 2003; 227: 18–36. [DOI] [PubMed] [Google Scholar]
- 10.Merhej S, Kanso C, Tomb L. Paratesticular fibrous pseudotumors. Prog Urol 2005; 15: 739–741. [PubMed] [Google Scholar]
- 11.Kim W, Rosen MA, Langer JE, et al. US MR imaging correlation in pathologic conditions of the scrotum. Radiographics 2007; 27: 1239–1253. [DOI] [PubMed] [Google Scholar]
- 12.Cassidy FH, Ishioka KM, McMahon CJ, et al. MR imaging of scrotal tumors and pseudotumors. Radiographics 2010; 30: 665–683. [DOI] [PubMed] [Google Scholar]
- 13.Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver – update 2012. Ultraschall Med 2013; 34: 11–29. [DOI] [PubMed] [Google Scholar]
- 14.Piscaglia F, Nolsoe C, Dietrich CF, et al. The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 2012; 32: 33–59. [DOI] [PubMed] [Google Scholar]
- 15.Huang DY, Sidhu PS. Focal testicular lesions: colour Doppler ultrasound, contrast-enhanced ultrasound and tissue elastography as adjuvants to the diagnosis. Br J Radiol 2012; 85: S41–S53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Jaffer OS, Sidhu PS. Contrast-enhanced ultrasonography of the testes. Ultrasound Clin North Am 2013; 8: 509–523. [Google Scholar]
- 17.Lock G, Schmidt C, Helmich F, et al. Early experience with contrast enhanced ultrasound in the diagnosis of testicular masses; a feasibility study. Urology 2011; 77: 1049–1053. [DOI] [PubMed] [Google Scholar]
- 18.Isidori AM, Pozza C, Gianfrilli D, et al. Differential diagnosis of nonpalpable testicular lesions: qualitative and quantitative contrast-enhanced US of benign and malignant testicular tumors. Radiology 2014; 273: 606–618. [DOI] [PubMed] [Google Scholar]
- 19.Patel K, Sellars ME, Clarke JL, et al. Features of testicular epidermoid cysts on contrast enhanced ultrasound and real time elastography. J Ultrasound Med 2012; 31: 1115–1122. [DOI] [PubMed] [Google Scholar]
- 20.Patel K, Huang DY, Sidhu PS. Metachronous bilateral segmental testicular infarction: multi-parametric ultrasound imaging with grey-scale ultrasound, Doppler ultrasound, contrast enhanced ultrasound (CEUS) and real-time tissue elastography (RTE). J Ultrasound 2014; 17: 233–238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Yusuf GT, Konstantatou E, Sellars ME, et al. Multiparametric sonography of testicular hematomas. Features on grayscale, color Doppler, and contrast-enhanced sonography and strain elastography. J Ultrasound Med 2015; 34: 1319–1328. [DOI] [PubMed] [Google Scholar]
- 22.Bertolotto M, Derchi LE, Secil M, et al. Grayscale and color Doppler features of testicular lymphoma. J Ultrasound Med 2015; 34: 1139–1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Hedayati V, Sellars ME, Sharma DM, et al. Contrast-enhanced ultrasound in testicular trauma: role in directing exploration, debridement and organ salvage. Br J Radiol 2012; 85: e65–e68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Lung PF, Jaffer OS, Sellars ME, et al. Contrast enhanced ultrasound (CEUS) in the evaluation of focal testicular complications secondary to epididymitis. AJR Am J Roentgenol 2012; 199: W345–W354. [DOI] [PubMed] [Google Scholar]
- 25.Bertolotto M, Derchi LE, Sidhu PS, et al. Acute segmental testicular infarction at contrast-enhanced ultrasound: early features and changes during follow-up. AJR Am J Roentgenol 2011; 196: 834–841. [DOI] [PubMed] [Google Scholar]
- 26.Carroll BA, Gross DM. High frequency scrotal sonography. AJR Am J Roentgenol 1983; 140: 511–515. [DOI] [PubMed] [Google Scholar]
- 27.Benson CB, Doubilet PM, Richie JP. Sonography of the male genital tract. AJR Am J Roentgenol 1989; 153: 705–713. [DOI] [PubMed] [Google Scholar]
- 28.Rifkin MD, Kurtz AB, Pasto ME, et al. Diagnostic capabilities of high resolution scrotal ultrasonography: prospective evaluation. J Ultrasound Med 1985; 4: 13–19. [DOI] [PubMed] [Google Scholar]
- 29.Serra AD, Hriack H, Coakley AJ, et al. Inconclusive clinical and ultrasound evaluation of the scrotum: impact of magnetic resonance imaging on patient management and cost. Urology 1998; 51: 1018–1021. [DOI] [PubMed] [Google Scholar]
- 30.Cramer BM, Schlegel EA, Thueroff JW. MR imaging in the differential diagnosis of scrotal and testicular disease. Radiographics 1991; 11: 9–21. [DOI] [PubMed] [Google Scholar]
- 31.Yang DM, Kim SH, Kim HN, et al. Differential diagnosis of focal epididymal lesions with gray scale sonographic, color Doppler sonographic, and clinical features. J Ultrasound Med 2003; 22: 135–142. [DOI] [PubMed] [Google Scholar]





